Review of the Use of High-Dose Gadoteridol in the Magnetic Resonance Evaluation of Central Nervous System Tumors

High Dose ◽

Magnetic resonance imaging of central nervous system tumors

Biology of Brain Tumour ◽

10.1007/978-1-4613-2297-9_23 ◽

1986 ◽

pp. 173-178

Author(s):

Graeme M. Bydder

Keyword(s):

Magnetic Resonance Imaging ◽

Central Nervous System ◽

Nervous System ◽

Magnetic Resonance ◽

Resonance Imaging ◽

Feasibility of high-dose chemotherapy protocols to treat infants with malignant central nervous system tumors: Experience from a middle-income country

Pediatric Blood & Cancer ◽

10.1002/pbc.27464 ◽

2018 ◽

Vol 66 (1) ◽

pp. e27464 ◽

Cited By ~ 2

Author(s):

Alya Elshahoubi ◽

Eman Khattab ◽

Hadeel Halalsheh ◽

Kawther Khaleifeh ◽

Eric Bouffet ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

High Dose Chemotherapy ◽

Middle Income Country ◽

Income Country ◽

High Dose ◽

Middle Income ◽

Contrast-Enhanced Magnetic Resonance Imaging of Central Nervous System Tumors

Topics in Magnetic Resonance Imaging ◽

10.1097/01.rmr.0000245464.36148.dc ◽

2006 ◽

Vol 17 (2) ◽

pp. 89-106 ◽

Cited By ~ 42

Author(s):

Marco Essig ◽

Marc-Andr?? Weber ◽

Hendrik von Tengg-Kobligk ◽

Michael V. Knopp ◽

William T.C. Yuh ◽

...

Keyword(s):

Magnetic Resonance Imaging ◽

Central Nervous System ◽

Nervous System ◽

Magnetic Resonance ◽

Resonance Imaging ◽

Nervous System Tumors ◽

Contrast Enhanced

A PILOT TRIAL OF TANDEM AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION FOLLOWING HIGH-DOSE THIOTEPA AND CARBOPLATIN IN CHILDREN WITH POOR-RISK CENTRAL NERVOUS SYSTEM TUMORS

Pediatric Hematology and Oncology ◽

10.1080/08880010490501060 ◽

2004 ◽

Vol 21 (7) ◽

pp. 635-645 ◽

Cited By ~ 6

Author(s):

M. Fevzi Ozkaynak ◽

Claudio Sandoval ◽

Oya Levendoglu-Tugal ◽

Somasundaram Jayabose

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Cell Transplantation ◽

Peripheral Blood ◽

Progenitor Cell ◽

Pilot Trial ◽

Peripheral Blood Progenitor Cell ◽

High Dose ◽

High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1702475 ◽

2000 ◽

Vol 26 (2) ◽

pp. 153-160 ◽

Cited By ~ 28

Author(s):

V Papadakis ◽

IJ Dunkel ◽

LD Cramer ◽

E Kramer ◽

E Papadopoulos ◽

...

Keyword(s):

Central Nervous System ◽

Bone Marrow ◽

Nervous System ◽

High Risk ◽

Autologous Bone Marrow ◽

High Dose ◽

Nervous System Tumors ◽

Autologous Bone

High-Dose Multi-agent Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Children with Central Nervous System Tumors

Oncopediatrics ◽

10.15690/nco.v3i1.1526 ◽

2016 ◽

Vol 3 (1) ◽

pp. 24-35

Author(s):

A. G. Gevorgyan ◽

E. V. Morozova ◽

I. V. Kazantsev ◽

Y. A. Punanov ◽

S. A. Safonova ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

High Dose ◽

Hematopoietic Stem ◽

Nervous System Tumors ◽

Multi Agent

Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue

Pediatric Blood & Cancer ◽

10.1002/pbc.20781 ◽

2007 ◽

Vol 48 (3) ◽

pp. 278-284 ◽

Cited By ~ 36

Author(s):

Halldora K. Thorarinsdottir ◽

Brian Rood ◽

Naynesh Kamani ◽

Debbie Lafond ◽

Evelio Perez-Albuerne ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

High Dose Chemotherapy ◽

High Dose ◽

Nervous System Tumors ◽

Stem Cell Rescue ◽

Autologous Stem Cell Rescue

High-Dose Multi-agent Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Children with Central Nervous System Tumors

Oncopediatrics ◽

10.15690/onco.v3i1.1526 ◽

2016 ◽

Vol 3 (1) ◽

pp. 24-35 ◽

Cited By ~ 1

Author(s):

A.G. Gevorgyan ◽

◽

E.V. Morozova ◽

I.V. Kazantsev ◽

Y.A. Punanov ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

High Dose ◽

Hematopoietic Stem ◽

Nervous System Tumors ◽

Multi Agent

EPT-23TREATMENT OF HIGH-GRADE CENTRAL NERVOUS SYSTEM TUMORS WITH HIGH-DOSE METHOTREXATE IN COMBINATION WITH MULTI-AGENT CHEMOTHERAPY: A SINGLE INSTITUTION EXPERIENCE

Neuro-Oncology ◽

10.1093/neuonc/now069.22 ◽

2016 ◽

Vol 18 (suppl 3) ◽

pp. iii29-iii29

Author(s):

Elizabeth Alva ◽

Gregory Friedman ◽

Rong Li ◽

Curtis Rozzelle ◽

Brandon Rocque ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

High Dose ◽

High Grade ◽

High Dose Methotrexate ◽

Single Institution ◽

Nervous System Tumors ◽

Dose Methotrexate ◽

Multi Agent

Treatment of pediatric high‐grade central nervous system tumors with high‐dose methotrexate in combination with multiagent chemotherapy: A single‐institution experience

Pediatric Blood & Cancer ◽

10.1002/pbc.28119 ◽

2019 ◽

Vol 67 (3) ◽

Cited By ~ 1

Author(s):

Joshua D. Bernstock ◽

Elizabeth Alva ◽

Joshua L. Cohen ◽

Mina Lobbous ◽

Gustavo Chagoya ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

High Dose ◽

High Grade ◽

High Dose Methotrexate ◽

Single Institution ◽

Nervous System Tumors ◽

Dose Methotrexate ◽

Multiagent Chemotherapy